MOLECULAR DYNAMIC SIMULATION_RESULTS_AT1 AND AT2 RECEPTOR

dataset

posted on 2024-01-30, 18:58 authored by Neyder Contreras-PuentesNeyder Contreras-Puentes

Angiotensin receptor blockers approved by the FDA were studied in order to study the link of regulation in the renin-angiotensin-aldosterone system at a central level that could be involved in aspects such as cognitive impairment, neuroplasticity and neurodegeneration, which may be linked to Alzheimer's disease.